At Melior Capital Management we specialise in providing funding to medtech, bioetch or pharmaceutical companies by applying institutional quality service and process to capital introduction and asset raising.
We seek prospective, individual investee projects with strong existing management, a willingness to work as part of a team, clearly identifiable Intellectual Property and the ability to focus on a financial exit for shareholders of between 3-6 years per deal.
We work exclusively and proactively with professional and institutional investors such as family offices, private banks, private wealth funds, pension funds and financial advisors, who provide shareholder capital to participate in individual deals as they are identified.
Our approach offers investors the benefit of deal transparency and direct access to uncorrelated alpha yet with the diversification of a portfolio as their number of Melior shareholdings increase. All in the knowledge that our due diligence and oversight is being conducted by a team with approaching 70 successful exits and numerous international awards to their credit.
Professional and institutional investors benefit from the reassurance of working with our team, who collectively during their personal careers have taken nearly 60 life-science businesses to market, of which the details of 66 of those deals are in the public domain. The track record of our team includes EU and North American IPOs, MHRA & US FDA approvals and a combined financial return for investors of c. US$23.4bn, represented by an average return / uplift per deal of c. $372m across thirty years.
Why work with us?
At Melior, we seek prospective, individual investee projects where opportunity and value present themselves.
To find these opportunities, we conduct intensive, bottom-up, fundamental research designed to identify companies that have – and can sustain – a competitive edge along with a strong management team that we believe can deliver for its shareholders. We know the companies in our universes in excruciating detail and only chose to work with those in which we truly believe.
Investees choose Melior Capital Management knowing they have a partner who cares as much about their future as they do. While we have a track record of delivering results, we are not constrained by structure or limited in response. We adapt to our clients’ needs. We listen, communicate and act.